What is the dosage and usage of Tranexamic acid for heavy menstrual bleeding or surgical patients?

Tranexamic Acid Dosing and Usage

Heavy Menstrual Bleeding

For heavy menstrual bleeding, administer tranexamic acid 1,300 mg orally three times daily (total 3.9 g/day) for up to 5 days during menstruation, starting on the first day of bleeding. 1, 2

Dosing Protocol

• Standard regimen: 1,300 mg PO three times daily (3.9-4 g/day total) for 4-5 days starting from day 1 of menstrual cycle 1, 2
• Alternative dosing studied: 1,000-1,500 mg three times daily for 3-5 days 2
• Treatment reduces menstrual blood loss by 26-60% compared to baseline 1

Efficacy Evidence

• Tranexamic acid is significantly more effective than placebo, NSAIDs (mefenamic acid, flurbiprofen), oral progestins, and etamsylate for reducing menstrual blood volume 1, 3, 2
• The levonorgestrel-releasing intrauterine system reduces menstrual blood loss more than tranexamic acid (96% reduction vs 34-59%), but 44% of patients develop amenorrhea which may be unacceptable 1, 2
• Quality of life improves significantly, with 81% of women satisfied and 94% reporting decreased bleeding 2

Safety Considerations for Menstrual Bleeding

• Adverse effects are predominantly mild gastrointestinal symptoms (nausea, vomiting, diarrhea, dyspepsia) occurring in approximately 12% of patients 1, 2
• No evidence exists of increased thrombotic events in women using tranexamic acid for menstrual bleeding 1, 4
• Absolute contraindication: Active thromboembolic disease 1, 4
• Use with extreme caution: Women on oral contraceptive pills due to theoretical increased thrombosis risk 5
• FDA warning: History of thrombosis/thromboembolism or intrinsic risk for thrombosis are contraindications in the US 6, 1

---

Surgical Bleeding (Trauma, Major Surgery, Postpartum Hemorrhage)

For surgical patients with active bleeding or high bleeding risk, administer tranexamic acid 1 gram IV over 10 minutes as a loading dose, followed by 1 gram IV infusion over 8 hours, with treatment initiated within 3 hours of bleeding onset for maximum efficacy. 6, 5

Standard Dosing Protocol

• Loading dose: 1 g IV over 10 minutes 6, 5
• Maintenance infusion: 1 g IV over 8 hours for procedures expected to exceed 2-3 hours or ongoing hemorrhage 5
• Alternative weight-based dosing: 10-15 mg/kg loading dose followed by 1-5 mg/kg/hour infusion 6

Critical Timing Window

• Administration must occur within 3 hours of bleeding onset for maximum benefit 5, 4
• Early administration (≤1 hour from injury) reduces bleeding death by 32% in trauma patients 5
• Efficacy decreases by 10% for every 15-minute delay in administration 5
• Administration after 3 hours may paradoxically increase bleeding death risk and should be avoided 5, 4

Clinical Indications by Specialty

Trauma

• European trauma guidelines recommend tranexamic acid for bleeding trauma patients, with Grade 1B recommendation for established hyperfibrinolysis 6
• CRASH-2 trial (20,000 patients) demonstrated 9% reduction in all-cause mortality and 15% reduction in bleeding-related death 5
• Standard trauma dosing: 1 g IV over 10 minutes followed by 1 g over 8 hours 6, 5

Postpartum Hemorrhage

• WHO strongly recommends early tranexamic acid (within 3 hours of birth) for all clinically diagnosed postpartum hemorrhage, regardless of cause (trauma or atony) 5
• Dosing: 1 g IV over 10 minutes, with second 1 g dose if bleeding continues after 30 minutes or restarts within 24 hours 5
• WOMAN trial demonstrated reduced maternal death due to bleeding 5

Cardiac and Major Non-Cardiac Surgery

• Reduces blood loss volume by mean difference of 268 mL in cardiac surgery 5
• Reduces reoperation risk (RR 0.53) and transfusion requirements (RR 0.67) 5
• Standard dosing: 1 g IV bolus prior to incision for procedures with high bleeding risk 5, 3

Benign Gynecologic Surgery

• Indicated for myomectomy and hysterectomy to reduce blood loss and transfusion requirements 7, 3
• Dosing: 1 g IV bolus over 10 minutes at start of surgery 7

Orthopedic Surgery (Femur Fractures)

• Strong recommendation from American Academy of Orthopaedic Surgeons: Administer to all patients undergoing femur fracture surgery 5
• Single-dose regimen: 1 g IV at start of surgical case, prior to incision 5
• No increased thromboembolic risk demonstrated in hip fracture patients 5

Safety Profile for Surgical Use

• Meta-analysis of 125,550 participants found no evidence of increased thromboembolic complications (risk difference = 0.001; 95% CI, -0.001 to 0.002) 5, 7
• No increased risk of myocardial infarction, stroke, DVT, or pulmonary embolism in over 8,000 patients 5
• High-dose tranexamic acid (≥4 g/24h) should NOT be used, particularly in critically ill patients with GI bleeding, as it increases DVT (RR 2.10), PE (RR 1.78), and seizure risk (RR 1.73) without mortality benefit 5

Absolute Contraindications

• Active intravascular clotting or disseminated intravascular coagulation 5, 7
• Active thromboembolic disease 5, 4
• Severe hypersensitivity to tranexamic acid 5

Relative Contraindications and Cautions

• Patients on oral contraceptive pills: Use with extreme caution due to increased thrombosis risk 5
• Massive hematuria: Use with extreme caution due to risk of ureteric obstruction from clot formation 5
• Post-stroke patients: Use with caution due to thrombotic concerns 5
• Severe renal impairment: Requires dose adjustment as tranexamic acid is 90% renally excreted; accumulation increases risk of neurotoxicity and seizures 6, 7

Key Clinical Pitfalls to Avoid

• Do not delay administration waiting for laboratory results or viscoelastic monitoring - early administration is critical for efficacy 5
• Do not administer after 3 hours from bleeding onset - may cause harm 5, 4
• Do not use high doses (>100 mg/kg total, especially in cardiac surgery patients >50 years) - associated with increased seizure risk 4
• Do not withhold due to thrombotic concerns in appropriate bleeding scenarios - mortality benefit from reduced bleeding far outweighs theoretical thrombotic risk 5